Patent Rights For Algorithmic Biocomputing Innovations In SustAInability.

06 Apr 2026 --
0 Comments

1. Understanding the Field: Algorithmic Biocomputing in Sustainability

Algorithmic biocomputing innovations are technologies that combine computational algorithms with biological processes. Examples in sustainability include:

Predictive models for carbon capture in plants.
Algorithms for optimizing microbial biofuel production.
AI-driven gene-editing platforms to improve crop resilience.
Computational platforms for waste-to-energy bioconversion.

Patentability issues arise because:

Algorithms per se are abstract ideas under patent law.
Biological inventions may be patentable, but must be new, non-obvious, and useful.
Hybrid innovations (algorithm + biotech) often face scrutiny under both sections of patent law: software and biotechnological inventions.

2. Legal Framework

US Law (35 U.S.C. §101): Limits patents to “processes, machines, manufactures, or compositions of matter.” Abstract ideas (like pure algorithms) are not patentable unless applied to a novel practical implementation.
European Patent Convention (EPC): Article 52 excludes mathematical methods “as such,” but allows biotech applications that solve a technical problem.
Indian Patent Law (Sections 3 & 8): Excludes mere algorithms, but biotechnology inventions with industrial applicability can be patented.

3. Key Cases: Algorithmic and Biotech Patent Rights

Case 1: Diamond v. Diehr (1981) – US Supreme Court

Facts: Diehr developed a method for curing synthetic rubber using a mathematical algorithm to calculate curing time.
Issue: Whether a process that uses a mathematical algorithm is patentable.
Ruling: The Supreme Court held that a process implementing an algorithm in a real-world industrial application is patentable.
Implication: Algorithms used in biocomputing for sustainability, such as optimizing biofuel production, can be patentable if applied in a technical process.

Case 2: Mayo Collaborative Services v. Prometheus (2012) – US Supreme Court

Facts: Prometheus had a patent for measuring metabolite levels to optimize drug dosing.
Issue: Whether the combination of a natural law and routine measurement steps is patentable.
Ruling: The Court invalidated the patent as it merely applied a natural law using conventional steps.
Implication: Biocomputing algorithms must go beyond mere observation of natural phenomena. If an algorithm just models natural processes without innovative steps, it may not be patentable.

Case 3: Association for Molecular Pathology v. Myriad Genetics (2013) – US Supreme Court

Facts: Myriad patented isolated BRCA1 and BRCA2 genes linked to breast cancer.
Issue: Are naturally occurring genes patentable?
Ruling: Naturally occurring genes cannot be patented, but cDNA (synthetic DNA) can be.
Implication: In sustainability-focused biocomputing, if an algorithm interacts with engineered biological sequences, it may support a patentable invention. Simply discovering a natural pathway is insufficient.

Case 4: Alice Corp. v. CLS Bank International (2014) – US Supreme Court

Facts: Alice patented a computer-implemented scheme for financial transactions.
Issue: Is implementing an abstract idea on a computer patentable?
Ruling: Abstract ideas implemented on generic computers are not patentable.
Implication: Algorithmic biocomputing innovations need a novel technical solution, not just software running routine tasks, to qualify for patents.

Case 5: Harvard College v. Canada (Commissioner of Patents) (2002) – Canada Supreme Court

Facts: Harvard College tried to patent genetically modified mice for research.
Ruling: The Court recognized that non-obvious, non-naturally occurring organisms could be patented.
Implication: Biocomputing innovations that engineer organisms (e.g., microbes that break down plastics) may be patentable even when algorithmically designed, provided the organism is novel and useful.

Case 6: Greenberg v. Miami Children’s Hospital Research Institute (2003) – US Federal Circuit

Facts: Greenberg claimed patents on genetically engineered DNA sequences for medical use.
Issue: Scope of patenting DNA sequences and associated algorithms.
Ruling: Patents were partially valid because the sequences were isolated and modified.
Implication: Hybrid inventions (algorithmically generated gene sequences) can be patented if applied and non-obvious.

4. Summary of Principles from Cases

Application matters: Algorithms must be applied in a practical, technical process (Diehr, Alice).
Novelty and non-obviousness: Hybrid biocomputing solutions must go beyond natural phenomena (Mayo, Myriad).
Biological modification: Engineered biological entities can be patented, but naturally occurring ones cannot (Myriad, Harvard College).
Algorithm-biology synergy: The combination of algorithmic computation + biotech device or organism may qualify if it produces a technological effect.

5. Practical Example in Sustainability

Imagine a biocomputing platform that designs microbes to sequester CO₂:

Algorithm: Predicts metabolic pathways.
Biological element: Microbes engineered using CRISPR.
Patent strategy: Claim the microbe + algorithmic process for its design, not just the software or natural microbe.
Legal support: Diamond v. Diehr (algorithm applied), Myriad (engineered sequences), Harvard College (modified organism).

This combination shows why algorithmic biocomputing can be patented in sustainability, but careful drafting and technical implementation are critical.